6.
der Beek T, Weber F, Bergmann A, Hickmann S, Ebert I, Hein A
. Pharmaceuticals in the environment--Global occurrences and perspectives. Environ Toxicol Chem. 2015; 35(4):823-35.
DOI: 10.1002/etc.3339.
View
7.
Bailey C
. Metformin: historical overview. Diabetologia. 2017; 60(9):1566-1576.
DOI: 10.1007/s00125-017-4318-z.
View
8.
Batt A, Kincaid T, Kostich M, Lazorchak J, Olsen A
. Evaluating the extent of pharmaceuticals in surface waters of the United States using a National-scale Rivers and Streams Assessment survey. Environ Toxicol Chem. 2015; 35(4):874-81.
DOI: 10.1002/etc.3161.
View
9.
Briones R, Sarmah A, Padhye L
. A global perspective on the use, occurrence, fate and effects of anti-diabetic drug metformin in natural and engineered ecosystems. Environ Pollut. 2016; 219:1007-1020.
DOI: 10.1016/j.envpol.2016.07.040.
View
10.
Brocker C, Velenosi T, Flaten H, McWilliams G, McDaniel K, Shelton S
. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genomics. 2020; 14(1):10.
PMC: 7066769.
DOI: 10.1186/s40246-020-00260-w.
View
11.
Calza P, Jimenez-Holgado C, Coha M, Chrimatopoulos C, Dal Bello F, Medana C
. Study of the photoinduced transformations of sertraline in aqueous media. Sci Total Environ. 2020; 756:143805.
DOI: 10.1016/j.scitotenv.2020.143805.
View
12.
Carvalho I, Santos L
. Antibiotics in the aquatic environments: A review of the European scenario. Environ Int. 2016; 94:736-757.
DOI: 10.1016/j.envint.2016.06.025.
View
13.
cetojevic-Simin D, Armakovic S, Sojic D, Abramovic B
. Toxicity assessment of metoprolol and its photodegradation mixtures obtained by using different type of TiO2 catalysts in the mammalian cell lines. Sci Total Environ. 2013; 463-464:968-74.
DOI: 10.1016/j.scitotenv.2013.06.083.
View
14.
Chaudhury A, Duvoor C, Dendi V, Kraleti S, Chada A, Ravilla R
. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front Endocrinol (Lausanne). 2017; 8:6.
PMC: 5256065.
DOI: 10.3389/fendo.2017.00006.
View
15.
Conley J, Symes S, Kindelberger S, Richards S
. Rapid liquid chromatography-tandem mass spectrometry method for the determination of a broad mixture of pharmaceuticals in surface water. J Chromatogr A. 2008; 1185(2):206-15.
DOI: 10.1016/j.chroma.2008.01.064.
View
16.
Dahlen A, Dashi G, Maslov I, Attwood M, Jonsson J, Trukhan V
. Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales. Front Pharmacol. 2022; 12:807548.
PMC: 8807560.
DOI: 10.3389/fphar.2021.807548.
View
17.
de Barros A, Schmidt F, de Aquino S, Afonso R
. Determination of nine pharmaceutical active compounds in surface waters from Paraopeba River Basin in Brazil by LTPE-HPLC-ESI-MS/MS. Environ Sci Pollut Res Int. 2018; 25(20):19962-19974.
DOI: 10.1007/s11356-018-2123-y.
View
18.
Oliveira de Farias N, Oliveira R, Sousa-Moura D, de Oliveira R, Rodrigues M, Andrade T
. Exposure to low concentration of fluoxetine affects development, behaviour and acetylcholinesterase activity of zebrafish embryos. Comp Biochem Physiol C Toxicol Pharmacol. 2018; 215:1-8.
DOI: 10.1016/j.cbpc.2018.08.009.
View
19.
Dinh Q, Moreau-Guigon E, Labadie P, Alliot F, Teil M, Blanchard M
. Occurrence of antibiotics in rural catchments. Chemosphere. 2016; 168:483-490.
DOI: 10.1016/j.chemosphere.2016.10.106.
View
20.
Edinoff A, Akuly H, Hanna T, Ochoa C, Patti S, Ghaffar Y
. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol Int. 2021; 13(3):387-401.
PMC: 8395812.
DOI: 10.3390/neurolint13030038.
View